Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 23 11:19AM ET
0.1500
Dollar change
+0.0200
Percentage change
15.38
%
Index- P/E- EPS (ttm)-4.75 Insider Own55.83% Shs Outstand3.62M Perf Week1.63%
Market Cap1.19M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.51M Perf Month-28.91%
Income-14.74M PEG- EPS next Q- Inst Own2.24% Short Float0.61% Perf Quarter-77.36%
Sales9.61M P/S0.12 EPS this Y- Inst Trans-48.53% Short Ratio0.25 Perf Half Y-59.46%
Book/sh0.12 P/B1.22 EPS next Y- ROA-98.83% Short Interest0.02M Perf Year-88.72%
Cash/sh0.15 P/C1.01 EPS next 5Y- ROE-417.94% 52W Range0.13 - 1.43 Perf YTD-75.04%
Dividend Est.- P/FCF- EPS past 5Y62.10% ROI-399.05% 52W High-89.51% Beta2.27
Dividend TTM- Quick Ratio0.37 Sales past 5Y1.57% Gross Margin21.10% 52W Low19.90% ATR (14)0.06
Dividend Ex-Date- Current Ratio0.52 EPS Y/Y TTM77.39% Oper. Margin-63.33% RSI (14)36.44 Volatility15.76% 36.15%
Employees25 Debt/Eq7.80 Sales Y/Y TTM-7.53% Profit Margin-153.43% Recom1.00 Target Price5.00
Option/ShortNo / Yes LT Debt/Eq2.80 EPS Q/Q88.67% Payout- Rel Volume0.04 Prev Close0.13
Sales Surprise-29.23% EPS Surprise-585.71% Sales Q/Q6.42% Earnings- Avg Volume85.53K Price0.15
SMA20-13.84% SMA50-62.41% SMA200-78.70% Trades Volume1,220 Change15.38%
Date Action Analyst Rating Change Price Target Change
May-23-18Initiated H.C. Wainwright Buy
Dec-22-15Downgrade Maxim Group Buy → Hold
Nov-17-15Reiterated Maxim Group Buy $7 → $1
Sep-21-15Upgrade H.C. Wainwright Neutral → Buy $2
May-15-15Downgrade H.C. Wainwright Buy → Neutral
Jun-26-14Initiated H.C. Wainwright Buy $5
Apr-24-14Initiated Maxim Group Buy $7
Jun-12-24 10:06AM
08:39AM
07:46AM
Jun-05-24 07:35AM
May-17-24 10:52PM
10:26AM Loading…
Nov-14-23 10:26AM
07:25AM
Nov-13-23 04:05PM
Nov-08-23 08:31AM
Oct-26-23 04:30PM
Sep-06-23 08:30AM
Aug-12-23 09:26AM
Aug-11-23 06:48AM
Aug-10-23 04:05PM
Aug-08-23 03:25PM
01:20PM Loading…
Jul-17-23 01:20PM
Jul-07-23 08:32AM
May-16-23 10:03AM
May-15-23 04:05PM
May-10-23 08:30AM
May-04-23 05:15PM
Apr-17-23 08:21AM
Apr-09-23 10:22AM
Apr-02-23 09:08AM
Mar-30-23 04:05PM
Mar-28-23 08:30AM
Mar-20-23 06:31PM
Mar-17-23 11:39AM
Mar-16-23 08:30AM
Mar-15-23 02:12PM
01:51PM Loading…
01:51PM
08:30AM
Mar-02-23 07:25PM
Jan-11-23 08:30AM
Dec-21-22 09:08AM
Nov-13-22 07:32AM
Nov-10-22 07:15PM
04:05PM
Nov-07-22 01:20PM
Oct-28-22 12:47PM
Oct-25-22 09:11PM
Oct-23-22 08:22AM
Oct-11-22 11:54AM
Sep-07-22 08:30AM
Aug-11-22 02:35PM
Aug-09-22 01:43PM
May-19-22 04:05PM
May-18-22 08:30AM
May-15-22 10:58AM
May-09-22 05:25PM
May-05-22 07:15PM
Mar-28-22 04:05PM
Mar-23-22 08:30AM
Mar-14-22 09:35AM
Jan-11-22 01:00PM
Jan-10-22 08:30AM
Dec-17-21 02:16PM
Dec-06-21 12:50PM
Nov-12-21 04:05PM
Nov-05-21 08:30AM
Nov-04-21 03:01PM
Sep-14-21 08:30AM
Sep-07-21 08:30AM
Aug-12-21 06:15PM
04:05PM
Aug-06-21 03:00PM
Aug-05-21 01:50PM
Jun-08-21 07:29AM
May-13-21 04:05PM
02:30PM
May-06-21 08:30AM
Apr-30-21 04:55PM
Mar-17-21 04:05PM
02:30PM
Mar-10-21 08:30AM
Feb-17-21 08:30AM
Feb-03-21 08:30AM
Jan-07-21 08:30AM
Dec-10-20 04:31AM
Nov-12-20 04:05PM
02:30PM
Nov-05-20 08:30AM
Oct-20-20 08:30AM
Sep-11-20 03:34PM
Sep-02-20 08:30AM
Aug-31-20 08:30AM
Aug-14-20 04:05PM
Aug-13-20 08:30AM
Aug-11-20 04:05PM
Aug-05-20 08:30AM
Jun-23-20 01:38PM
Jun-16-20 08:30AM
Jun-11-20 08:30AM
Jun-08-20 01:07PM
May-28-20 02:42PM
May-18-20 08:57AM
May-14-20 04:05PM
May-07-20 08:30AM
Apr-24-20 08:30AM
Apr-16-20 08:45AM
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, CAR-Txpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Xu XiaochunCEONov 17 '23Sale1.02600,000612,000327,121Nov 21 07:30 AM